SC 13G Filing

Company

Aptevo Therapeutics Inc.

Filed

February 12, 2019

Accession Number

0001037389-19-000008

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →